IIM
SLDB icon

INTECH Investment Management’s Solid Biosciences SLDB Stock Holding History

INTECH Investment Management’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$163K Sell
16,302
-276
-2% -$2.09K ﹤0.01% 1843
2026
Q1 		$119K Sell
16,578
-17,907
-52% -$115K ﹤0.01% 1865
2025
Q4 		$194K Buy
34,485
+4,539
+15% +$24.6K ﹤0.01% 2000
2025
Q3 		$185K Sell
29,946
-6,416
-18% -$37.5K ﹤0.01% 2100
2025
Q2 		$177K Buy
36,362
+18,619
+105% +$65.8K ﹤0.01% 2131
2025
Q1 		$65.6K Buy
17,743
+6,878
+63% +$29.4K ﹤0.01% 2396
2024
Q4 		$43.5K Buy
+10,865
New +$59.7K ﹤0.01% 2342

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

INTECH Investment Management's SLDB Position: Q2 2026 in Review

INTECH Investment Management reduced its Solid Biosciences (SLDB) stake by 1.7% in Q2 2026, selling an estimated $2.09K and leaving 16,302 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #1843.

INTECH Investment Management first reported a position in SLDB in Q4 2024 and has held it in 7 quarters since. The position peaked at $194K in Q4 2025. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • INTECH Investment Management held 16,302 shares of Solid Biosciences worth $163K as of Q2 2026.
  • INTECH Investment Management sold 276 Solid Biosciences shares in Q2 2026, an estimated $2.09K.
  • Solid Biosciences made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1843 holding.
  • INTECH Investment Management first reported a position in Solid Biosciences in Q4 2024 and has held it in 7 quarters since.
  • INTECH Investment Management's Solid Biosciences position peaked at $194K in Q4 2025.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.